Skip to main content
. 2020 May 29;10:8777. doi: 10.1038/s41598-020-65324-2

Figure 7.

Figure 7

(A) Representative platelet poor plasma (PPP) smears with added anti-E. coli LPS antibody and secondary antibody, from healthy individuals and colorectal cancer (CRC) patients. Micrographs were enhanced for publication clarity, by adjusting the brightness and contrast of the images in Adobe Photoshop CS6. (B) Box and whisker plot of the normalised (to secondary antibody control signal) mean fluorescence intensities (MFIs) of healthy (n = 29) (left box) and CRC (n = 25) (right box) PPP smears, with added anti-E. coli LPS antibody and secondary antibody.